We Are Metabolon

Metabolomics, the large-scale study of all small molecules in a biological system, is the only ‘omics technology that provides a complete current-state functional readout of a biological system. Metabolomics helps researchers see beyond the genetic variation of individuals, capturing the combined impact of genetic and external factors such as the effect of drugs, diet, lifestyle, and the microbiome on human health. By measuring thousands of discrete chemical signals that form biological pathways in the body, metabolomics can help researchers understand what it means to be well and healthy and elucidate disease and other biological development mechanisms and markers. From a therapeutic perspective, metabolomics can reveal important biomarkers enabling a better understanding of potential therapeutic targets, biological and drug-related mechanisms of action, pharmacodynamics, and safety profiles, as well as individual responses to therapy.

Metabolon’s Global Discovery Panel leverages our market-leading platform and the world’s largest proprietary metabolomics reference library to quickly and accurately identify small molecule metabolites in a biological sample. With this data, our Data and Translational Science (DTS) experts help customers and partners worldwide address some of the most challenging and pressing questions in the life sciences, accelerating research and enhancing development success across the pharmaceutical, biotechnology, consumer products, agriculture, and nutrition industries, as well as academic and government organizations.

Metabolon has the ability to deliver unique and high-quality insights for our clients. We offer scalable, customizable metabolomics and lipidomics solutions delivering relative and absolute quantitative bioanalytical data, biomarker discoveries and innovative diagnostic tests to support customer needs from discovery through clinical trials and product life-cycle management.